Skip to main content
SpringerLink
Log in

Irritable Bowel Syndrome: Diagnosis

  • Chapter
  • First Online:
Introduction to Gastrointestinal Diseases Vol. 1

Abstract

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder diagnosed on symptom-based criteria without inclusion of any objective parameter measurable by known diagnostic methods. Heterogeneity of patient’s symptoms and overlapping with more serious organic diseases increase uncertainty for the physician’s work and enhance the cost of confirming the diagnosis. In 2016 Rome IV criteria of functional disorders were published. These criteria are the basis to make a diagnosis in the daily work of medical doctors, especially general practitioners and gastroenterologists. Recent studies showed that in the future a combination of several new biomarkers could improve the diagnostic process of IBS. Among the studied biomarkers, most evidence is provided for fecal calprotectin. However, cut-off values for fecal calprotectin still have to be investigated prior to inclusion in the IBS diagnostic algorithm. In this chapter diagnosis criteria of IBS will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. National Collaborating Centre for Nursing and Supportive Care (2008) irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care

    Google Scholar 

  2. Amarenco G (2014) Bristol Stool Chart: étude prospective et monocentrique de «l’introspection fécale» chez des sujets volontaires [Bristol stool chart: prospective and monocentric study of ‘stools introspection’ in healthy subjects]. Progrès en Urologie (in French) 24(11):708–713

    Article  CAS  Google Scholar 

  3. Rome IV. Functional Gastrointestinal Disorders. Disorders of Gut-Brain Interaction. Douglas A. Drossman, Senior Editor. 2016

    Google Scholar 

  4. http://www.romecriteria.org/

  5. El-Salhy M (2012) Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol 18(37):5151–5163

    Article  PubMed  PubMed Central  Google Scholar 

  6. Aronson J (2005) Biomarkers and surrogate endpoints. Br J Clin Pharmacol 59(5):491–494. doi:10.1111/j.1365-2125.2005.02435.x.

  7. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95. doi:10.1067/mcp.2001.113989

    Article  Google Scholar 

  8. Clarke G, Quigley EMM, Cryan JF, Dinan TG (2009) Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 15(10):478–489. doi:10.1016/j.molmed.2009.08.001

    Article  CAS  PubMed  Google Scholar 

  9. Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7(2):169–177. doi:10.1016/S0969-2126(99)80023-9

    Article  CAS  PubMed  Google Scholar 

  10. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. The Journal of Clinical Investigation 111(12):1805–1812. doi:10.1172/JCI18921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288(5):H2031–H2041. doi:10.1152/ajpheart.01058.2004

    Article  CAS  PubMed  Google Scholar 

  12. Mantovani A, Garlanda C, Doni A, Bottazzi B (2008) Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 28(1):1–13. doi:10.1007/s10875-007-9126-7

    Article  CAS  PubMed  Google Scholar 

  13. Hod K, Dickman R, Sperber A et al (2011) Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome. Neurogastroenterol Motil 23(12):1105–1110. doi:10.1111/j.1365-2982.2011.01788.x

    Article  CAS  PubMed  Google Scholar 

  14. ESR (2013) MedlinePlus: U.S. National Library of Medicine and National Institutes of Health. Retrieved 8 July 2013

    Google Scholar 

  15. Hauser G, Tkalcic M, Pletikosic S, Grabar N, Stimac D (2012) Erythrocyte sedimentation rate—possible role in determining the existence of the low grade inflammation in Irritable bowel syndrome patients. Med Hypotheses 78(6):818–820. doi:10.1016/j.mehy.2012.03.020

    Article  PubMed  Google Scholar 

  16. Scott E (2011) Cortisol and stress: how to stay healthy. About.com. Retrieved 29 Nov 2011

    Google Scholar 

  17. Hoehn K, Marieb EN (2010) Human anatomy and physiology. Benjamin Cummings, San Francisco. ISBN 0-321-60261-7

    Google Scholar 

  18. Chyun YS, Kream BE, Raisz LG (1984) Cortisol decreases bone formation by inhibiting periosteal cell proliferation. Endocrinology 114(2):477–480. doi:10.1210/endo-114-2-477

    Article  CAS  PubMed  Google Scholar 

  19. Chitkara DK, van Tilburg MAL, Blois-Martin N, Whitehead WE (2008) Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol 103(3):765–774. doi:10.1111/j.1572-0241.2007.01722.x

    Article  PubMed  Google Scholar 

  20. Blanchard EB, Lackner JM, Jaccard J et al (2008) The role of stress in symptom exacerbation among IBS patients. J Psychosom Res 64(2):119–128. doi:10.1016/j.jpsychores.2007.10.010

    Article  PubMed  Google Scholar 

  21. Kennedy PJ, Cryan JF, Quigley EM, Dinan TG, Clarke G (2014) A sustained hypothalamic-pituitary-adrenal axis response to acute psychosocial stress in irritable bowel syndrome. Psychol Med 44(14):3123–3134. doi:10.1017/s003329171400052x

    Article  CAS  PubMed  Google Scholar 

  22. FitzGerald LZ, Kehoe P, Sinha K (2009) Hypothalamic-pituitary-adrenal axis dysregulation in women with irritable bowel syndrome in response to acute physical stress. West J Nurs Res 31(7):818–836. doi:10.1177/0193945909339320

    Article  PubMed  Google Scholar 

  23. Helman LJ, Ahn TG, Levine MA, Allison A, Cohen PS, Cooper MJ, Cohn DV, Israel MA (1988) Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J Biol Chem 263(23):11559–11563

    Article  CAS  PubMed  Google Scholar 

  24. Wu JT, Erickson AJ, Tsao KC, Wu TL, Sun CF (2000) Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages. Ann Clin Lab Sci 30(2):175–178

    PubMed  Google Scholar 

  25. Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M (2005) Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Hepatogastroenterology 52(63):731–741

    PubMed  Google Scholar 

  26. Zhang D, Shooshtarizadeh P, Laventie B-J et al (2009) Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS One 4(2). doi:10.1371/journal.pone.0004501.e4501

  27. Sidhu R, McAlindon ME, Leeds JS, Skilling J, Sanders DS (2009) The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome. J Gastrointest Liver Dis 18(1):23–26

    Google Scholar 

  28. Dunlop SP, Jenkins D, Neal KR, Spiller RC (2003) Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125(6):1651–1659. doi:10.1053/j.gastro.2003.09.028

    Article  PubMed  Google Scholar 

  29. Sidhu R, Drew K, McAlindon ME, Lobo AJ, Sanders DS (2010) Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis? Inflamm Bowel Dis 16(3):361. doi:10.1002/ibd.20982

    Article  PubMed  Google Scholar 

  30. El-Salhy M, Lomholt-Beck B, Hausken T (2010) Chromogranin a as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol 45(12):1435–1439. doi:10.3109/00365521.2010.503965

    Article  CAS  PubMed  Google Scholar 

  31. Öhman L, Stridsberg M, Isaksson S, Jerlstad P, Simrén M (2012) Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol 107(3):440–447. doi:10.1038/ajg.2011.458

    Article  CAS  PubMed  Google Scholar 

  32. Brophy MB, Nolan EM (2015) Manganese and microbial pathogenesis: sequestration by the mammalian immune system and utilization by microorganisms. ACS Chem Biol 10(3):641–651. doi:10.1021/cb500792b

  33. Chen CC, Huang JL, Chang CJ, Kong MS (2012) Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr 55(5):541–547

    Article  CAS  PubMed  Google Scholar 

  34. Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease. Gut 54(3):364–368

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I (2002) Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123(2):450–460. doi:10.1053/gast.2002.34755

    Article  PubMed  Google Scholar 

  36. Waugh N, Cummins E, Royle P et al (2013) Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess 17(55). doi:10.3310/hta17550

  37. Chang M-H, Chou J-W, Chen S-M et al (2014) Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Molecular Medicine Reports. 10(1):522–526. doi:10.3892/mmr.2014.2180

    Article  CAS  PubMed  Google Scholar 

  38. Tkalcic M, Pletikosic S, Hausr G (2014) Biological and psychological determinants of health related quality of life in irritable bowel syndrome patients. J Psychosom Res 76(6):516. doi:10.1016/j.jpsychores.2014.03.086

    Article  Google Scholar 

  39. Sawai MV, Jia HP, Liu L, Aseyev V, Wiencek JM, McCray PB Jr, Ganz T, Kearney WR, Tack BF (2001) The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry 40(13):3810–3816

    Google Scholar 

  40. Schröder JM, Harder J (1999) Human beta-defensin-2. Int J Biochem Cell Biol 31(6):645–651

    Article  PubMed  Google Scholar 

  41. Langhorst J, Junge A, Rueffer A et al (2009) Elevated human β-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 104(2):404–410

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland

    Marcin Włodarczyk & Aleksandra Sobolewska-Włodarczyk

  2. Department of General and Colorectal Surgery, Faculty of Military Medicine, Medical University of Lodz, Hallera Sq 1, 90-647, Lodz, Poland

    Marcin Włodarczyk

  3. Department of Gastroenterology, Faculty of Military Medicine, Medical University of Lodz, Hallera Sq 1, 90-647, Lodz, Poland

    Aleksandra Sobolewska-Włodarczyk

Authors
  1. Marcin Włodarczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aleksandra Sobolewska-Włodarczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcin Włodarczyk .

Editor information

Editors and Affiliations

  1. Department of Biochemistry, Medical University of Lodz, Lodz, Poland

    Jakub Fichna

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Włodarczyk, M., Sobolewska-Włodarczyk, A. (2017). Irritable Bowel Syndrome: Diagnosis. In: Fichna, J. (eds) Introduction to Gastrointestinal Diseases Vol. 1. Springer, Cham. https://doi.org/10.1007/978-3-319-49016-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49016-8_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49015-1

  • Online ISBN: 978-3-319-49016-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation